Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L.

Fig. 6

Effect of SM or nano-SM on hepatic (A) NF-ҡB and (B) IL-1β expressions. The results are presented as means ± SE. a, b, c, d Significant difference from normal, EE, EE + UDCA, and EE + SM groups at p < 0.05, respectively. EE: 17α-ethinylestradiol; UDCA: Ursodeoxycholic acid; SM: Silybum marianum L.; NF-kβ: nuclear factor kappa- β; IL-1Ⓡ: Interleukin-1β

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us